Abstract

Tourette’s syndrome (TS) is a childhood onset neuropsychiatric disorder. The underlying pathogenesis of TS remains unclear. A human induced pluripotent stem cell (hiPSC) line, derived from the peripheral blood mononuclear cells (PBMCs) from a TS patient, was generated by the reprogramming with episomal vectors expressing OCT4, SOX2, KLF4 and c-MYC. The generated hiPSC line is free of episomal vectors, with normal karyotype, expressing pluripotency markers and can differentiate into three germ layers in vivo. This hiPSC line from TS patient can offer a useful resource for studying the pathological mechanism of TS and screening effective drugs for therapeutic purpose.